JA
About
Jams has more than 14 years of venture capital experience and three years of operational experience in life science companies. His directorships have included Chroma Therapeutics, Clinical Designs and Syntaxin. He joined Abingworth as CFO in 1998, prior to which he was CFO of Prolifix from 1995 to 1998. He trained and qualified as a Chartered Accountant with KPMG. He holds a degree in Biology with Chemistry from the University of Southampton. James handles Abingworth’s finance and administration as well as investment matters, focusing on start-up companies.
Position in the VCSift Database
- • 18 investors at Abingworth are tracked.
- • 1 investors hold the Partner and CFO role in VCSift. James Abell is one of them.
- • 8,972 investors are based in London, England, United Kingdom.
Data sourced from 410,343 investor profiles. Updated May 2026.
Investment Focus
- Location
- London, UK
Contact Information
linkedin.com/in/••••••••
Find more investors like James
Search Investors